Press Releases
Apr. 17, 2026
Landmark Lancet Study Demonstrates Safety and Efficacy of Magnetic Seizure Therapy in Depression
Neutral
EIN Presswire
Mar. 28, 2026
Europe Faces Energy Shock as Middle East Conflict Escalates
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Apr. 17, 2026
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
Indeterminate
GlobeNewswire, Inc.
Apr. 17, 2026
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
Indeterminate
GlobeNewswire, Inc.
Apr. 16, 2026
Evaxion concludes Annual General Meeting
Indeterminate
GlobeNewswire, Inc.
Mar. 25, 2026
US to Expanded Army Access in Greenland Amid Talks with Denmark
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 24, 2026
Voting Kicks Off in Denmark as Closest Election in Years Looms
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 23, 2026
Groundbreaking Danish research project launches to cure Parkinson’s disease
Indeterminate
GlobeNewswire, Inc.
Mar. 20, 2026
Delegation Visit to Denmark: Strengthening Dialogue on the Future of Work
Gov't Institution
Government of Slovenia
Owner: Slovenian Government
Apr. 16, 2026
BioVerde and Unibio Partner on Methane-Based Route to Butadiene and Other Chemical Intermediates
Neutral
EIN Presswire
Apr. 15, 2026
Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe
Indeterminate
GlobeNewswire, Inc.
Apr. 16, 2026
Freya Biosciences announces positive Phase 1 first-in-human data with FB301 for IVF-related embryo implantation failure
Indeterminate
GlobeNewswire, Inc.
Apr. 14, 2026
Major Shareholder Announcement
Indeterminate
GlobeNewswire, Inc.
Apr. 14, 2026
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
Indeterminate
GlobeNewswire, Inc.
Apr. 15, 2026
FREUDENBERG HAS COMPLETED THE VOLUNTARY PUBLIC TAKEOVER OFFER OF NILFISK HOLDING A/S
Indeterminate
GlobeNewswire, Inc.